UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: diagnostics

The future of Organ-On-A-Chip

Bas Trietsch is the CTO and co-founder of MIMETAS and co-inventor of the OrganoPlate. As CTO he currently drives the continued product development of the OrganoPlate and its peripheral equipment.

Here, Bas talks about what the future holds for organ-on-a-chip and other breakthroughs technologies in biology.

Read More

Precision Medicine: Molecular Phenotyping, Diagnostic Development & Patient Subpopulations

As industry developments continue to improve, the potential for personalised medicine and the possibility of individual diagnosis is on the horizon. These slides, from the Precision Medicine & Biomarkers Leaders Summit: Europe are now available from Andres Hurtado-Lorenzo, Thorsten Gutjahr & Thomas Skot Jensen.

Read More

Neurobehavioural Screening, Microfabricated Platforms and Medical Device Innovation with Microfluidics

Microfluidics is revolutionising the way patients are diagnosed, monitored and treated. If you weren’t able to attend the 4BIO Summit in San Francisco, we have made these presentation slides from Suvajyoti Guha, Dr Todd Thorsen & Pouya Rezai available here.

Read More

How to cope with an evolving Immuno-Oncology field and changes in pathology

2018 will be remembered as a decisive year for immuno-oncology. In particular, Nobel Prize winners James Allison of MD Anderson Cancer Center in Houston, Texas, and Tasuku Honjo of Kyoto University in Japan lifted the field of immunotherapy to international recognition for those outside the scientific and medical communities. For the patient, these new alternatives to standard oncology therapies offer new hope for life-extending treatments using immunotherapy.

Read More

Failing Blockbuster Medicines, Eroding Operator Margins & Increased Pricing Pressures: What’s Next for Precision Medicine?

The Precision Medicine and Biomarkers Leaders Summit: Europe takes place this week and in anticipation, we spoke to Unmesh Lal of Frost and Sullivan about his views on what the future holds for precision medicine and how the pharmaceutical industry has changed in recent times.

Read More

Tele-Consultation Systems for Today’s Pathologists

Pathology is dealing with an area of diagnostics that is extremely variable. General pathologists are able to diagnose virtually any disease, but in rare or complex cases it is common practice to consult an expert.

Read More

Honey Reddi on Liquid Biopsies and her Predictions for Precision Medicine

Honey Reddi, Clinical Laboratory Director at the Jackson Laboratory spoke at the 4th Global Precision Medicine and Biomarkers Leader Summit. She gives us an insight on liquid biopsies in the clinic and the effectiveness of current treatment.

Read More

Molecular Diagnostics for the Point of Care

Here, we use the term molecular diagnostics to refer to tests that detect the presence of specific nucleic acids in a clinical specimen such as blood, urine, faeces, saliva, and tissue. These nucleic acids serve, among other things, as biomarkers for the presence of infection-causing pathogens (e.g., DNA and/or RNA from bacteria, virus, and/or parasites); diseases such as cancer (characterised by mutant alleles), and genetic abnormalities.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive